{"id":46218,"date":"2018-12-20T09:00:53","date_gmt":"2018-12-20T14:00:53","guid":{"rendered":"https:\/\/wfh.org\/article\/la-fmh-fait-sienne-la-recommandation-du-conseil-medical-et-scientifique-de-la-nhf-sur-les-risques-relatifs-aux-essais-cliniques-en-therapie-genique\/"},"modified":"2024-04-22T14:39:36","modified_gmt":"2024-04-22T18:39:36","slug":"la-fmh-fait-sienne-la-recommandation-du-conseil-medical-et-scientifique-de-la-nhf-sur-les-risques-relatifs-aux-essais-cliniques-en-therapie-genique","status":"publish","type":"post","link":"https:\/\/wfh.org\/fr\/article\/la-fmh-fait-sienne-la-recommandation-du-conseil-medical-et-scientifique-de-la-nhf-sur-les-risques-relatifs-aux-essais-cliniques-en-therapie-genique\/","title":{"rendered":"La FMH fait sienne la recommandation du Conseil m\u00e9dical et scientifique de la NHF sur les risques relatifs aux essais cliniques en th\u00e9rapie g\u00e9nique"},"content":{"rendered":"\t\t<div data-elementor-type=\"wp-post\" data-elementor-id=\"46218\" class=\"elementor elementor-46218 elementor-46182\" data-elementor-post-type=\"post\">\n\t\t\t\t\t\t<section class=\"elementor-section elementor-top-section elementor-element elementor-element-57c8eeb elementor-section-boxed elementor-section-height-default elementor-section-height-default\" data-id=\"57c8eeb\" data-element_type=\"section\">\n\t\t\t\t\t\t<div class=\"elementor-container elementor-column-gap-default\">\n\t\t\t\t\t<div class=\"elementor-column elementor-col-100 elementor-top-column elementor-element elementor-element-036aa4a\" data-id=\"036aa4a\" data-element_type=\"column\">\n\t\t\t<div class=\"elementor-widget-wrap elementor-element-populated\">\n\t\t\t\t\t\t<div class=\"elementor-element elementor-element-9f86c59 elementor-widget elementor-widget-text-editor\" data-id=\"9f86c59\" data-element_type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t<style>\/*! elementor - v3.23.0 - 25-07-2024 *\/\n.elementor-widget-text-editor.elementor-drop-cap-view-stacked .elementor-drop-cap{background-color:#69727d;color:#fff}.elementor-widget-text-editor.elementor-drop-cap-view-framed .elementor-drop-cap{color:#69727d;border:3px solid;background-color:transparent}.elementor-widget-text-editor:not(.elementor-drop-cap-view-default) .elementor-drop-cap{margin-top:8px}.elementor-widget-text-editor:not(.elementor-drop-cap-view-default) .elementor-drop-cap-letter{width:1em;height:1em}.elementor-widget-text-editor .elementor-drop-cap{float:left;text-align:center;line-height:1;font-size:50px}.elementor-widget-text-editor .elementor-drop-cap-letter{display:inline-block}<\/style>\t\t\t\t<p class=\"\">La recommandation du MASAC dresse un \u00e9tat des lieux des diff\u00e9rents aspects qu\u2019il convient de garder \u00e0 l\u2019esprit s\u2019agissant des essais cliniques en th\u00e9rapie g\u00e9nique. Elle soutient de tels essais cliniques chez l\u2019homme tout en soulignant l\u2019importance d\u2019identifier et de r\u00e9duire les risques encourus par les patients, de faire face aux risques encore inconnus li\u00e9s au processus des essais cliniques et de veiller \u00e0 maintenir une communication ouverte et continue sur les avanc\u00e9es enregistr\u00e9es avec les membres de la communaut\u00e9 concern\u00e9e par l\u2019h\u00e9mophilie.<\/p>\r\n\r\n<p class=\"\">Le <a href=\"https:\/\/wfh.org\/fr\/nos-comites\/\" target=\"_blank\" rel=\"noopener noreferrer\">Conseil consultatif m\u00e9dical de la FMH<\/a>\u00a0fait sienne la recommandation intitul\u00e9e \u00ab <em>MASAC Document Regarding Risks of Gene Therapy Trials for Hemophilia<\/em> \u00bb publi\u00e9e le 6 d\u00e9cembre 2018.<\/p>\r\n\r\n<p class=\"\">Veuillez cliquer <a href=\"https:\/\/www.hemophilia.org\/Researchers-Healthcare-Providers\/Medical-and-Scientific-Advisory-Council-MASAC\/MASAC-Recommendations\/MASAC-Document-Regarding-Risks-of-Gene-Therapy-Trials-for-Hemophilia\" target=\"_blank\" rel=\"noopener noreferrer\">ici<\/a> pour lire la recommandation publi\u00e9e par le MASAC.<\/p>\r\n\r\n<p class=\"\">Pour lire les observations de la FMH sur le document \u00ab <em>Draft Guidance for Industry: Human Gene Therapy for Hemophilia<\/em> \u00bb adress\u00e9es \u00e0 la Food and Drug Administration (FDA) am\u00e9ricaine, veuillez cliquer <a href=\"https:\/\/wfh.org\/wp-content\/uploads\/2022\/09\/WFH-Response-to-FDA-on-gene-therapy-Dec-2018.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">ici<\/a>\u00a0(uniquement en anglais).<\/p>\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t<\/div>\n\t\t","protected":false},"excerpt":{"rendered":"<p>Le 6 d\u00e9cembre 2018, le MASAC (Conseil consultatif m\u00e9dical et scientifique de la NHF) a rendu publique la recommandation n\u00b0 254 intitul\u00e9e \u00ab <em>MASAC Document Regarding Risks of Gene Therapy Trials for Hemophilia<\/em> \u00bb.<\/p>\n","protected":false},"author":3,"featured_media":29974,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"inline_featured_image":false,"footnotes":""},"categories":[177,197],"tags":[],"search-category":[319],"class_list":["post-46218","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-actualite-medicale","category-declarations-publiques-et-recommandations-de-la-fmh","search-category-article-fr"],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v23.4 (Yoast SEO v23.4) - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>La FMH fait sienne la recommandation du Conseil m\u00e9dical et scientifique de la NHF sur les risques relatifs aux essais cliniques en th\u00e9rapie g\u00e9nique | FMH - F\u00e9d\u00e9ration mondiale de l\u2019h\u00e9mophilie<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/wfh.org\/fr\/article\/la-fmh-fait-sienne-la-recommandation-du-conseil-medical-et-scientifique-de-la-nhf-sur-les-risques-relatifs-aux-essais-cliniques-en-therapie-genique\/\" \/>\n<meta property=\"og:locale\" content=\"fr_FR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"La FMH fait sienne la recommandation du Conseil m\u00e9dical et scientifique de la NHF sur les risques relatifs aux essais cliniques en th\u00e9rapie g\u00e9nique\" \/>\n<meta property=\"og:description\" content=\"Le 6 d\u00e9cembre 2018, le MASAC (Conseil consultatif m\u00e9dical et scientifique de la NHF) a rendu publique la recommandation n\u00b0 254 intitul\u00e9e \u00ab MASAC Document Regarding Risks of Gene Therapy Trials for Hemophilia \u00bb.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/wfh.org\/fr\/article\/la-fmh-fait-sienne-la-recommandation-du-conseil-medical-et-scientifique-de-la-nhf-sur-les-risques-relatifs-aux-essais-cliniques-en-therapie-genique\/\" \/>\n<meta property=\"og:site_name\" content=\"FMH - F\u00e9d\u00e9ration mondiale de l\u2019h\u00e9mophilie\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/wfhemophilia\/\" \/>\n<meta property=\"article:published_time\" content=\"2018-12-20T14:00:53+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2024-04-22T18:39:36+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/wfh.org\/wp-content\/uploads\/2021\/04\/WFH-trilingual-logo-EN.png\" \/>\n\t<meta property=\"og:image:width\" content=\"1277\" \/>\n\t<meta property=\"og:image:height\" content=\"603\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"Electra Rozakis\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"\u00c9crit par\" \/>\n\t<meta name=\"twitter:data1\" content=\"Electra Rozakis\" \/>\n\t<meta name=\"twitter:label2\" content=\"Dur\u00e9e de lecture estim\u00e9e\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/wfh.org\/fr\/article\/la-fmh-fait-sienne-la-recommandation-du-conseil-medical-et-scientifique-de-la-nhf-sur-les-risques-relatifs-aux-essais-cliniques-en-therapie-genique\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/wfh.org\/fr\/article\/la-fmh-fait-sienne-la-recommandation-du-conseil-medical-et-scientifique-de-la-nhf-sur-les-risques-relatifs-aux-essais-cliniques-en-therapie-genique\/\"},\"author\":{\"name\":\"Electra Rozakis\",\"@id\":\"https:\/\/wfh.org\/fr\/#\/schema\/person\/590cf0d3a057aaef67b154adeffbf31d\"},\"headline\":\"La FMH fait sienne la recommandation du Conseil m\u00e9dical et scientifique de la NHF sur les risques relatifs aux essais cliniques en th\u00e9rapie g\u00e9nique\",\"datePublished\":\"2018-12-20T14:00:53+00:00\",\"dateModified\":\"2024-04-22T18:39:36+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/wfh.org\/fr\/article\/la-fmh-fait-sienne-la-recommandation-du-conseil-medical-et-scientifique-de-la-nhf-sur-les-risques-relatifs-aux-essais-cliniques-en-therapie-genique\/\"},\"wordCount\":200,\"publisher\":{\"@id\":\"https:\/\/wfh.org\/fr\/#organization\"},\"image\":{\"@id\":\"https:\/\/wfh.org\/fr\/article\/la-fmh-fait-sienne-la-recommandation-du-conseil-medical-et-scientifique-de-la-nhf-sur-les-risques-relatifs-aux-essais-cliniques-en-therapie-genique\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/wfh.org\/wp-content\/uploads\/2021\/04\/WFH-trilingual-logo-EN.png\",\"articleSection\":[\"Actualit\u00e9 m\u00e9dicale\",\"D\u00e9clarations publiques et recommandations de la FMH\"],\"inLanguage\":\"fr-FR\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/wfh.org\/fr\/article\/la-fmh-fait-sienne-la-recommandation-du-conseil-medical-et-scientifique-de-la-nhf-sur-les-risques-relatifs-aux-essais-cliniques-en-therapie-genique\/\",\"url\":\"https:\/\/wfh.org\/fr\/article\/la-fmh-fait-sienne-la-recommandation-du-conseil-medical-et-scientifique-de-la-nhf-sur-les-risques-relatifs-aux-essais-cliniques-en-therapie-genique\/\",\"name\":\"La FMH fait sienne la recommandation du Conseil m\u00e9dical et scientifique de la NHF sur les risques relatifs aux essais cliniques en th\u00e9rapie g\u00e9nique | FMH - F\u00e9d\u00e9ration mondiale de l\u2019h\u00e9mophilie\",\"isPartOf\":{\"@id\":\"https:\/\/wfh.org\/fr\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/wfh.org\/fr\/article\/la-fmh-fait-sienne-la-recommandation-du-conseil-medical-et-scientifique-de-la-nhf-sur-les-risques-relatifs-aux-essais-cliniques-en-therapie-genique\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/wfh.org\/fr\/article\/la-fmh-fait-sienne-la-recommandation-du-conseil-medical-et-scientifique-de-la-nhf-sur-les-risques-relatifs-aux-essais-cliniques-en-therapie-genique\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/wfh.org\/wp-content\/uploads\/2021\/04\/WFH-trilingual-logo-EN.png\",\"datePublished\":\"2018-12-20T14:00:53+00:00\",\"dateModified\":\"2024-04-22T18:39:36+00:00\",\"inLanguage\":\"fr-FR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/wfh.org\/fr\/article\/la-fmh-fait-sienne-la-recommandation-du-conseil-medical-et-scientifique-de-la-nhf-sur-les-risques-relatifs-aux-essais-cliniques-en-therapie-genique\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\/\/wfh.org\/fr\/article\/la-fmh-fait-sienne-la-recommandation-du-conseil-medical-et-scientifique-de-la-nhf-sur-les-risques-relatifs-aux-essais-cliniques-en-therapie-genique\/#primaryimage\",\"url\":\"https:\/\/wfh.org\/wp-content\/uploads\/2021\/04\/WFH-trilingual-logo-EN.png\",\"contentUrl\":\"https:\/\/wfh.org\/wp-content\/uploads\/2021\/04\/WFH-trilingual-logo-EN.png\",\"width\":1277,\"height\":603,\"caption\":\"stock\"},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/wfh.org\/fr\/#website\",\"url\":\"https:\/\/wfh.org\/fr\/\",\"name\":\"FMH - F\u00e9d\u00e9ration mondiale de l\u2019h\u00e9mophilie\",\"description\":\"WFH - World Federation of Hemophilia\",\"publisher\":{\"@id\":\"https:\/\/wfh.org\/fr\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/wfh.org\/fr\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"fr-FR\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/wfh.org\/fr\/#organization\",\"name\":\"World Federation of Hemophilia\",\"url\":\"https:\/\/wfh.org\/fr\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\/\/wfh.org\/fr\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/wfh.org\/wp-content\/uploads\/2021\/10\/WFH-LOGO-ENGLISH.svg\",\"contentUrl\":\"https:\/\/wfh.org\/wp-content\/uploads\/2021\/10\/WFH-LOGO-ENGLISH.svg\",\"width\":210,\"height\":63,\"caption\":\"World Federation of Hemophilia\"},\"image\":{\"@id\":\"https:\/\/wfh.org\/fr\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/wfhemophilia\/\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/wfh.org\/fr\/#\/schema\/person\/590cf0d3a057aaef67b154adeffbf31d\",\"name\":\"Electra Rozakis\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"La FMH fait sienne la recommandation du Conseil m\u00e9dical et scientifique de la NHF sur les risques relatifs aux essais cliniques en th\u00e9rapie g\u00e9nique | FMH - F\u00e9d\u00e9ration mondiale de l\u2019h\u00e9mophilie","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/wfh.org\/fr\/article\/la-fmh-fait-sienne-la-recommandation-du-conseil-medical-et-scientifique-de-la-nhf-sur-les-risques-relatifs-aux-essais-cliniques-en-therapie-genique\/","og_locale":"fr_FR","og_type":"article","og_title":"La FMH fait sienne la recommandation du Conseil m\u00e9dical et scientifique de la NHF sur les risques relatifs aux essais cliniques en th\u00e9rapie g\u00e9nique","og_description":"Le 6 d\u00e9cembre 2018, le MASAC (Conseil consultatif m\u00e9dical et scientifique de la NHF) a rendu publique la recommandation n\u00b0 254 intitul\u00e9e \u00ab MASAC Document Regarding Risks of Gene Therapy Trials for Hemophilia \u00bb.","og_url":"https:\/\/wfh.org\/fr\/article\/la-fmh-fait-sienne-la-recommandation-du-conseil-medical-et-scientifique-de-la-nhf-sur-les-risques-relatifs-aux-essais-cliniques-en-therapie-genique\/","og_site_name":"FMH - F\u00e9d\u00e9ration mondiale de l\u2019h\u00e9mophilie","article_publisher":"https:\/\/www.facebook.com\/wfhemophilia\/","article_published_time":"2018-12-20T14:00:53+00:00","article_modified_time":"2024-04-22T18:39:36+00:00","og_image":[{"width":1277,"height":603,"url":"https:\/\/wfh.org\/wp-content\/uploads\/2021\/04\/WFH-trilingual-logo-EN.png","type":"image\/png"}],"author":"Electra Rozakis","twitter_card":"summary_large_image","twitter_misc":{"\u00c9crit par":"Electra Rozakis","Dur\u00e9e de lecture estim\u00e9e":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/wfh.org\/fr\/article\/la-fmh-fait-sienne-la-recommandation-du-conseil-medical-et-scientifique-de-la-nhf-sur-les-risques-relatifs-aux-essais-cliniques-en-therapie-genique\/#article","isPartOf":{"@id":"https:\/\/wfh.org\/fr\/article\/la-fmh-fait-sienne-la-recommandation-du-conseil-medical-et-scientifique-de-la-nhf-sur-les-risques-relatifs-aux-essais-cliniques-en-therapie-genique\/"},"author":{"name":"Electra Rozakis","@id":"https:\/\/wfh.org\/fr\/#\/schema\/person\/590cf0d3a057aaef67b154adeffbf31d"},"headline":"La FMH fait sienne la recommandation du Conseil m\u00e9dical et scientifique de la NHF sur les risques relatifs aux essais cliniques en th\u00e9rapie g\u00e9nique","datePublished":"2018-12-20T14:00:53+00:00","dateModified":"2024-04-22T18:39:36+00:00","mainEntityOfPage":{"@id":"https:\/\/wfh.org\/fr\/article\/la-fmh-fait-sienne-la-recommandation-du-conseil-medical-et-scientifique-de-la-nhf-sur-les-risques-relatifs-aux-essais-cliniques-en-therapie-genique\/"},"wordCount":200,"publisher":{"@id":"https:\/\/wfh.org\/fr\/#organization"},"image":{"@id":"https:\/\/wfh.org\/fr\/article\/la-fmh-fait-sienne-la-recommandation-du-conseil-medical-et-scientifique-de-la-nhf-sur-les-risques-relatifs-aux-essais-cliniques-en-therapie-genique\/#primaryimage"},"thumbnailUrl":"https:\/\/wfh.org\/wp-content\/uploads\/2021\/04\/WFH-trilingual-logo-EN.png","articleSection":["Actualit\u00e9 m\u00e9dicale","D\u00e9clarations publiques et recommandations de la FMH"],"inLanguage":"fr-FR"},{"@type":"WebPage","@id":"https:\/\/wfh.org\/fr\/article\/la-fmh-fait-sienne-la-recommandation-du-conseil-medical-et-scientifique-de-la-nhf-sur-les-risques-relatifs-aux-essais-cliniques-en-therapie-genique\/","url":"https:\/\/wfh.org\/fr\/article\/la-fmh-fait-sienne-la-recommandation-du-conseil-medical-et-scientifique-de-la-nhf-sur-les-risques-relatifs-aux-essais-cliniques-en-therapie-genique\/","name":"La FMH fait sienne la recommandation du Conseil m\u00e9dical et scientifique de la NHF sur les risques relatifs aux essais cliniques en th\u00e9rapie g\u00e9nique | FMH - F\u00e9d\u00e9ration mondiale de l\u2019h\u00e9mophilie","isPartOf":{"@id":"https:\/\/wfh.org\/fr\/#website"},"primaryImageOfPage":{"@id":"https:\/\/wfh.org\/fr\/article\/la-fmh-fait-sienne-la-recommandation-du-conseil-medical-et-scientifique-de-la-nhf-sur-les-risques-relatifs-aux-essais-cliniques-en-therapie-genique\/#primaryimage"},"image":{"@id":"https:\/\/wfh.org\/fr\/article\/la-fmh-fait-sienne-la-recommandation-du-conseil-medical-et-scientifique-de-la-nhf-sur-les-risques-relatifs-aux-essais-cliniques-en-therapie-genique\/#primaryimage"},"thumbnailUrl":"https:\/\/wfh.org\/wp-content\/uploads\/2021\/04\/WFH-trilingual-logo-EN.png","datePublished":"2018-12-20T14:00:53+00:00","dateModified":"2024-04-22T18:39:36+00:00","inLanguage":"fr-FR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/wfh.org\/fr\/article\/la-fmh-fait-sienne-la-recommandation-du-conseil-medical-et-scientifique-de-la-nhf-sur-les-risques-relatifs-aux-essais-cliniques-en-therapie-genique\/"]}]},{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/wfh.org\/fr\/article\/la-fmh-fait-sienne-la-recommandation-du-conseil-medical-et-scientifique-de-la-nhf-sur-les-risques-relatifs-aux-essais-cliniques-en-therapie-genique\/#primaryimage","url":"https:\/\/wfh.org\/wp-content\/uploads\/2021\/04\/WFH-trilingual-logo-EN.png","contentUrl":"https:\/\/wfh.org\/wp-content\/uploads\/2021\/04\/WFH-trilingual-logo-EN.png","width":1277,"height":603,"caption":"stock"},{"@type":"WebSite","@id":"https:\/\/wfh.org\/fr\/#website","url":"https:\/\/wfh.org\/fr\/","name":"FMH - F\u00e9d\u00e9ration mondiale de l\u2019h\u00e9mophilie","description":"WFH - World Federation of Hemophilia","publisher":{"@id":"https:\/\/wfh.org\/fr\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/wfh.org\/fr\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"fr-FR"},{"@type":"Organization","@id":"https:\/\/wfh.org\/fr\/#organization","name":"World Federation of Hemophilia","url":"https:\/\/wfh.org\/fr\/","logo":{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/wfh.org\/fr\/#\/schema\/logo\/image\/","url":"https:\/\/wfh.org\/wp-content\/uploads\/2021\/10\/WFH-LOGO-ENGLISH.svg","contentUrl":"https:\/\/wfh.org\/wp-content\/uploads\/2021\/10\/WFH-LOGO-ENGLISH.svg","width":210,"height":63,"caption":"World Federation of Hemophilia"},"image":{"@id":"https:\/\/wfh.org\/fr\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/wfhemophilia\/"]},{"@type":"Person","@id":"https:\/\/wfh.org\/fr\/#\/schema\/person\/590cf0d3a057aaef67b154adeffbf31d","name":"Electra Rozakis"}]}},"_links":{"self":[{"href":"https:\/\/wfh.org\/fr\/wp-json\/wp\/v2\/posts\/46218"}],"collection":[{"href":"https:\/\/wfh.org\/fr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/wfh.org\/fr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/wfh.org\/fr\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/wfh.org\/fr\/wp-json\/wp\/v2\/comments?post=46218"}],"version-history":[{"count":2,"href":"https:\/\/wfh.org\/fr\/wp-json\/wp\/v2\/posts\/46218\/revisions"}],"predecessor-version":[{"id":46233,"href":"https:\/\/wfh.org\/fr\/wp-json\/wp\/v2\/posts\/46218\/revisions\/46233"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/wfh.org\/fr\/wp-json\/wp\/v2\/media\/29974"}],"wp:attachment":[{"href":"https:\/\/wfh.org\/fr\/wp-json\/wp\/v2\/media?parent=46218"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/wfh.org\/fr\/wp-json\/wp\/v2\/categories?post=46218"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/wfh.org\/fr\/wp-json\/wp\/v2\/tags?post=46218"},{"taxonomy":"search-category","embeddable":true,"href":"https:\/\/wfh.org\/fr\/wp-json\/wp\/v2\/search-category?post=46218"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}